Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Peripheral Painful Traumatic Trigeminal Neuropathy
NCT03555916Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2019
- Primary completion
- Jul 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in trigeminal neuropathy (TNO), sponsored by Assistance publique - Hôpitaux de Paris. Started Apr 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
trigeminal neuropathy (TNO)
Beyond the preview
Go deeper on NCT03555916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03555916.